Allan B. Dietz

Allan B. Dietz is a Professor of Laboratory Medicine and Pathology at Mayo Clinic College of Medicine and Science. He serves as Co-Director of the Human Cellular Therapy Lab at Mayo Clinic's Center for Regenerative Biotherapeutics, with dual appointments in the Department of Immunology and Division of Transfusion Medicine.

• 1986: BA in Biology and Chemistry from University of Northern Iowa
• 1992: PhD in Genetics from Texas A&M University
• 1993: Postdoctoral Fellowship at USDA Agricultural Research Service

His research spans cellular immunotherapy, stem cell biology, and regenerative medicine, with a focus on dendritic cell vaccines for cancers (CML, melanoma, glioblastoma), monocyte immunosuppression mechanisms, and mesenchymal stromal cell applications in GVHD and tissue repair (ALS, Crohn’s, renal stenosis, diabetes). Recent work includes microfluidic bioreactor development for cell therapy manufacturing and immune profiling for cancer patients.

Key publications from 2024-2025 include:

• Microfluidic bioreactors for dendritic cell production
• Pembrolizumab-ibrutinib melanoma trials
• Mesenchymal stem cells in spinal cord injury
• Multiorgan transplant immune management guidelines

Awarded:

• 2017 Mayo Clinic Team Science Award
• 1997 Voyles Fellowship in Stem Cell Biology
• 1991 Carrington Award for Cell Biology

Active in regulatory committees including FDA-compliant cell therapy oversight and ISCT North American meetings. Integrates laboratory findings with clinical workflows through Mayo Clinic's CCaTS and Center for Individualized Medicine programs.